Mihir R Patel1, Lauren Ottenstein2, Martha Ryan2, Annie Farrell2, Matthew Studer3, H Michael Baddour2, Kelly Magliocca4, Christopher Griffith5, William Stokes6, Jeffrey Switchenko7, Ashley Aiken8, Mark El-Deiry2, C Arturo Solares2, Conor Steuer9, Nabil Saba9, Jonathan Beitler6. 1. Department of Otolaryngology Head and Neck Surgery, Emory University School of Medicine, Atlanta, GA, United States. Electronic address: Mihir.r.patel@emory.edu. 2. Department of Otolaryngology Head and Neck Surgery, Emory University School of Medicine, Atlanta, GA, United States. 3. Emory University School of Medicine, Atlanta, GA, United States. 4. Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States. 5. Department of Pathology, Cleveland Clinic, Cleveland, OH, United States. 6. Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA, United States. 7. Department of Biostatistics and Bioinformatics, Emory University School of Medicine, Atlanta, GA, United States. 8. Department of Radiology and Imaging Services, Emory University School of Medicine, Atlanta, GA, United States. 9. Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States.
Abstract
OBJECTIVE: To determine the impact of diagnostic TORS lingual tonsillectomy (DTLT) on objective swallowing measures for carcinoma of unknown primary (CUP). METHODS: Between 10/2016-1/2020, 27 patients with p16+ squamous cell carcinoma (SCC) level 2a nodal disease underwent DTLT and ipsilateral neck dissection for CUP. No patient had a history of cutaneous SCC. Patients participated in Modified Barium Swallow (MBS) three weeks post-TORS, which were then compared to those from a contemporaneous cohort of 40 patients with clinically-identified p16+ base of tongue (BOT) primary tumors. DIGEST scores were retrospectively calculated. Univariate and multivariate analysis performed, stratified by BOT glossectomy (n = 40) versus lingual tonsillectomy for CUP (n = 27). Radiation to the resected primary or potential primary sources was omitted if margins were ≥3 mm or if no primary identified. RESULTS: Twenty-seven consecutive patients with clinical stage cT0N1 HPV-associated OPSCC had a BOT primary pathologically identified in 18/27 (67%). Univariate analysis of functional swallow assessment on MBSImP correlated with improved post-TORS DIGEST scores for CUP. On multivariate analysis (MVA) DIGEST safety scores were improved for CUP than cT1 BOT glossectomy [Odds Ratio (OR) 0.28, p = 0.038]. MVA on matched pT1 CUP (n = 27) vs. pT1 BOT (n = 19), OR of moderate/severe dysphagia for CUP was 0.54 [0.12-2.38, p = 0.417] for DIGEST safety scores and 0.27 [0.06-1.18, p = 0.082] for DIGEST efficiency scores. Moderate/severe dysphagia as determined by DIGEST overall scores for CUP compared to cT1 and pT1 yielded an OR of 0.39 (p = 0.081) and 0.42 (p = 0.195), respectively. Twenty-six total patients received adjuvant RT, and 18 (11 with ≥3 mm margins, 9 with negative specimens) were spared intentional RT to the oropharynx. Median follow-up was 22.6 months with 100% PFS. CONCLUSIONS: Patients undergoing DTLT for CUP demonstrated acute swallow defecits in the post-operative setting. A comparison of long-term functional results between DTLT and elective irradiation of the primary site should be studied. LEVEL OF EVIDENCE: Level III.
OBJECTIVE: To determine the impact of diagnostic TORS lingual tonsillectomy (DTLT) on objective swallowing measures for carcinoma of unknown primary (CUP). METHODS: Between 10/2016-1/2020, 27 patients with p16+ squamous cell carcinoma (SCC) level 2a nodal disease underwent DTLT and ipsilateral neck dissection for CUP. No patient had a history of cutaneous SCC. Patients participated in Modified Barium Swallow (MBS) three weeks post-TORS, which were then compared to those from a contemporaneous cohort of 40 patients with clinically-identified p16+ base of tongue (BOT) primary tumors. DIGEST scores were retrospectively calculated. Univariate and multivariate analysis performed, stratified by BOT glossectomy (n = 40) versus lingual tonsillectomy for CUP (n = 27). Radiation to the resected primary or potential primary sources was omitted if margins were ≥3 mm or if no primary identified. RESULTS: Twenty-seven consecutive patients with clinical stage cT0N1 HPV-associated OPSCC had a BOT primary pathologically identified in 18/27 (67%). Univariate analysis of functional swallow assessment on MBSImP correlated with improved post-TORS DIGEST scores for CUP. On multivariate analysis (MVA) DIGEST safety scores were improved for CUP than cT1 BOT glossectomy [Odds Ratio (OR) 0.28, p = 0.038]. MVA on matched pT1 CUP (n = 27) vs. pT1 BOT (n = 19), OR of moderate/severe dysphagia for CUP was 0.54 [0.12-2.38, p = 0.417] for DIGEST safety scores and 0.27 [0.06-1.18, p = 0.082] for DIGEST efficiency scores. Moderate/severe dysphagia as determined by DIGEST overall scores for CUP compared to cT1 and pT1 yielded an OR of 0.39 (p = 0.081) and 0.42 (p = 0.195), respectively. Twenty-six total patients received adjuvant RT, and 18 (11 with ≥3 mm margins, 9 with negative specimens) were spared intentional RT to the oropharynx. Median follow-up was 22.6 months with 100% PFS. CONCLUSIONS: Patients undergoing DTLT for CUP demonstrated acute swallow defecits in the post-operative setting. A comparison of long-term functional results between DTLT and elective irradiation of the primary site should be studied. LEVEL OF EVIDENCE: Level III.
Authors: Christopher H Rassekh; Bert W O'Malley; Arnaud F Bewley; Kathleen T Montone; Virginia A Livolsi; Gregory S Weinstein Journal: Head Neck Date: 2016-03-29 Impact factor: 3.147
Authors: Primož Strojan; Alfio Ferlito; Jesus E Medina; Julia A Woolgar; Alessandra Rinaldo; K Thomas Robbins; Johannes J Fagan; William M Mendenhall; Vinidh Paleri; Carl E Silver; Kerry D Olsen; June Corry; Carlos Suárez; Juan P Rodrigo; Johannes A Langendijk; Kenneth O Devaney; Luiz P Kowalski; Dana M Hartl; Missak Haigentz; Jochen A Werner; Phillip K Pellitteri; Remco de Bree; Gregory T Wolf; Robert P Takes; Eric M Genden; Michael L Hinni; Vanni Mondin; Ashok R Shaha; Leon Barnes Journal: Head Neck Date: 2011-10-27 Impact factor: 3.147
Authors: Lea Schroeder; Paolo Boscolo-Rizzo; Elisa Dal Cin; Salvatore Romeo; Lorena Baboci; Gerhard Dyckhoff; Jochen Hess; Carlota Lucena-Porcel; Anne Byl; Nikolaus Becker; Laia Alemany; Xavier Castellsagué; Miquel Quer; Xavier León; Manuel Wiesenfarth; Michael Pawlita; Dana Holzinger Journal: Eur J Cancer Date: 2017-02-10 Impact factor: 9.162
Authors: Shayan Cheraghlou; Sina J Torabi; Zain A Husain; Michael D Otremba; Heather A Osborn; Saral Mehra; Wendell G Yarbrough; Barbara A Burtness; Benjamin L Judson Journal: Laryngoscope Date: 2018-08-27 Impact factor: 3.325
Authors: Jens P Klussmann; Elif Gültekin; Soenke J Weissenborn; Ulrike Wieland; Volker Dries; Hans P Dienes; Hans E Eckel; Herbert J Pfister; Pawel G Fuchs Journal: Am J Pathol Date: 2003-03 Impact factor: 4.307
Authors: Patrick Tassone; Meghan Crawley; Cory Bovenzi; Tingting Zhan; William Keane; David Cognetti; Adam Luginbuhl; Joseph Curry Journal: Ann Otol Rhinol Laryngol Date: 2017-02-16 Impact factor: 1.547
Authors: Katherine A Hutcheson; Martha P Barrow; Denise A Barringer; Jodi K Knott; Heather Y Lin; Randal S Weber; Clifton D Fuller; Stephen Y Lai; Clare P Alvarez; Janhavi Raut; Cathy L Lazarus; Annette May; Joanne Patterson; Justin W G Roe; Heather M Starmer; Jan S Lewin Journal: Cancer Date: 2016-08-26 Impact factor: 6.860